Companies / GILD vs TECH
GILD vs TECH: Gilead Sciences and Bio-Techne
Gilead Sciences (GILD) reported $29.4B in revenue against a 28.9% net margin, while Bio-Techne (TECH) reported $1.2B at a 15.0% net margin, most recently.
| Metric | GILD | TECH |
|---|---|---|
| Revenue | $29.4B | $1.2B |
| Net Income | $8.5B | $0.2B |
| Gross Margin | 78.8% | 65.8% |
| Operating Margin | 34.0% | 20.7% |
| EPS (Diluted) | $6.78 | $1.16 |
| Free Cash Flow | $9.5B | $0.3B |
| Total Debt | $24.9B | $0.2B |
| P/E Ratio | 18.1× | 60.9× |
| P/B Ratio | 6.7× | 5.2× |
| Stock Price | $167.53 | $72.66 |
Free: last 5 years
| Fiscal year | FY2009 🔒 | FY2010 🔒 | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2015 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GILD Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $27.3B | $27.3B | $27.1B | $28.8B | $29.4B |
| TECH Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | — | $1.1B | $1.1B | $1.2B | $1.2B |